Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd W Scheithauer

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Plos Medicine|February 20, 2009
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patientNinette Amariglio, Abraham Hirshberg, Bernd W Scheithauer, et al.
Journal of the Peripheral Nervous System : JPNS|November 3, 2010
Inflammatory pseudotumor of nerve: clinicopathological characteristics and a potential therapyMichelle L Mauermann, Bernd W Scheithauer, Robert J Spinner, et al.
The American Journal of Surgical Pathology|March 27, 2003
Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expressionDavid H George, Bernd W Scheithauer, Fügen V Aker, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 20, 2008
Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissuesFausto J Rodriguez, Jeffrey D Gamez, Julie A Vrana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalitiesJan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
European Journal of Clinical Investigation|November 9, 2012
ACTH-secreting Crooke cell carcinoma of the pituitaryGábor L Kovács, Miklós Góth, Fabio Rotondo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experienceJames L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Neurosurgery|August 3, 2006
Pathobiology of pituitary adenomas and carcinomasBernd W Scheithauer, Thomas A Gaffey, Ricardo V Lloyd, et al.
Genes & Cancer|September 3, 2010
A Postnatal Pax7 Progenitor Gives Rise to Pituitary AdenomasTohru Hosoyama, Koichi Nishijo, Melinda M Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 TrialsJan C Buckner, Karla V Ballman, John C Michalak, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Plos Medicine|February 20, 2009
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patientNinette Amariglio, Abraham Hirshberg, Bernd W Scheithauer, et al.
Journal of the Peripheral Nervous System : JPNS|November 3, 2010
Inflammatory pseudotumor of nerve: clinicopathological characteristics and a potential therapyMichelle L Mauermann, Bernd W Scheithauer, Robert J Spinner, et al.
The American Journal of Surgical Pathology|March 27, 2003
Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expressionDavid H George, Bernd W Scheithauer, Fügen V Aker, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 20, 2008
Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissuesFausto J Rodriguez, Jeffrey D Gamez, Julie A Vrana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalitiesJan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
European Journal of Clinical Investigation|November 9, 2012
ACTH-secreting Crooke cell carcinoma of the pituitaryGábor L Kovács, Miklós Góth, Fabio Rotondo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experienceJames L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Neurosurgery|August 3, 2006
Pathobiology of pituitary adenomas and carcinomasBernd W Scheithauer, Thomas A Gaffey, Ricardo V Lloyd, et al.
Genes & Cancer|September 3, 2010
A Postnatal Pax7 Progenitor Gives Rise to Pituitary AdenomasTohru Hosoyama, Koichi Nishijo, Melinda M Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 TrialsJan C Buckner, Karla V Ballman, John C Michalak, et al.
Pageof 27